KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial.
Li-Tzong Chen
No relevant relationships to disclose
Jen-Shi Chen
No relevant relationships to disclose
Yee Chao
No relevant relationships to disclose
Chang-Sung Tsai
No relevant relationships to disclose
Yan-Shen Shan
No relevant relationships to disclose
Chiun Hsu
No relevant relationships to disclose
Shiu-Feng Huang
No relevant relationships to disclose
Hsiao-Hui Tsou
No relevant relationships to disclose
Kuan-Der Lee
No relevant relationships to disclose
Chang-Fang Chiu
No relevant relationships to disclose
Kun-Ming Rau
No relevant relationships to disclose
Ching-Liang Ho
No relevant relationships to disclose
Ming-Sun Yu
No relevant relationships to disclose